Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
61.97
+1.79 (2.97%)
At close: Oct 28, 2025, 4:00 PM EDT
63.00
+1.03 (1.66%)
After-hours: Oct 28, 2025, 4:36 PM EDT
Cytokinetics Market Cap
Cytokinetics has a market cap or net worth of $7.42 billion as of October 28, 2025. Its market cap has increased by 18.57% in one year.
Market Cap
7.42B
Enterprise Value
7.49B
1-Year Change
18.57%
Ranking
Category
Stock Price
$61.97
Market Cap Chart
Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $7.42B, an increase of 1,668.46%. That is a compound annual growth rate of 14.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 7.20B | 29.72% |
| Dec 31, 2024 | 5.55B | -32.19% |
| Dec 29, 2023 | 8.19B | 88.80% |
| Dec 30, 2022 | 4.34B | 13.41% |
| Dec 31, 2021 | 3.82B | 159.95% |
| Dec 31, 2020 | 1.47B | 134.61% |
| Dec 31, 2019 | 626.90M | 81.29% |
| Dec 31, 2018 | 345.80M | -21.27% |
| Dec 29, 2017 | 439.20M | -10.79% |
| Dec 30, 2016 | 492.30M | 21.17% |
| Dec 31, 2015 | 406.30M | 38.57% |
| Dec 31, 2014 | 293.20M | 52.87% |
| Dec 31, 2013 | 191.80M | 104.04% |
| Dec 31, 2012 | 94.00M | 35.45% |
| Dec 30, 2011 | 69.40M | -49.60% |
| Dec 31, 2010 | 137.70M | -22.34% |
| Dec 31, 2009 | 177.30M | 25.83% |
| Dec 31, 2008 | 140.90M | -39.40% |
| Dec 31, 2007 | 232.50M | -17.84% |
| Dec 29, 2006 | 283.00M | 51.01% |
| Dec 30, 2005 | 187.40M | -35.49% |
| Dec 31, 2004 | 290.50M | -30.72% |
| Apr 30, 2004 | 419.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |